24
ntibacterial susceptibility testin

Antibacterial susceptibility testing

  • Upload
    brit

  • View
    89

  • Download
    5

Embed Size (px)

DESCRIPTION

Antibacterial susceptibility testing. Drug classes Methods for testing Laboratory strategies. Basic principles of antimicrobial action. 1.Agent is in active form - pharmacodynamics: structure & route 2.Achieve sufficient levels at site of infection - pharmacokinetics. - PowerPoint PPT Presentation

Citation preview

Page 1: Antibacterial susceptibility testing

Antibacterial susceptibility testing

Page 2: Antibacterial susceptibility testing

Drug classes

Methods for testing

Laboratory strategies

Page 3: Antibacterial susceptibility testing

Basic principles of antimicrobial action

1. Agent is in active form- pharmacodynamics: structure & route

2. Achieve sufficient levels at site of infection- pharmacokinetics

Page 4: Antibacterial susceptibility testing

Serum CSF Urine

Ampicillin + + +Ceftriaxone + + +Vancomycin + ± +Ciprofloxacin + ± +Gentamicin + - +Clindamycin + - -Norfloxacin - - +Nitrofurantoin - - +

Anatomic distribution

Page 5: Antibacterial susceptibility testing

Basic principles of antimicrobial action

3. Adsorption of drug by organism

4. Intracellular uptake

5. Target binding

6. Growth inhibition (bacteriostatic) or death (bactericidal)

- Resistance can develop at any point

Page 6: Antibacterial susceptibility testing

Mechanisms of action

Beta-lactams

Penicillins, cephalosporins, carbapenemsInhibit cell wall synthesis by binding PBPsActive against many Gram + and Gram – (varies)

Aminoglycosides

Gentamicin, tobramycin, amikacin, streptomycinInhibit protein synthesis (30S ribosomal subunit)Gram + and Gram – but not anaerobes

Page 7: Antibacterial susceptibility testing

http://www.life.umd.edu/classroom/bsci424/Definitions.htm

Beta-lactams

Page 8: Antibacterial susceptibility testing

http://gsbs.utmb.edu/microbook/ch011.htm

Aminoglycosides

Page 9: Antibacterial susceptibility testing

Mechanisms of action

Fluoroquinolones

Ciprofloxacin, levofloxacinInhibit DNA synthesis by binding to gyrasesActive against many Gram + and Gram – (varies)

Glycopeptides

VancomycinInhibit cell wall synthesis by binding precursorsGram + only

Page 10: Antibacterial susceptibility testing

http://gsbs.utmb.edu/microbook/ch011.htm

Quinolones

Glycopeptide

Page 11: Antibacterial susceptibility testing

Mechanisms of action

Macrolides-lincosamides

Erythromycin, azithromycin, clindamycinInhibit protein synthesis (50S ribosomal subunit)Most Gram + and some Gram –

Tetracyclines

Tetracycline, doxycyclineInhibit protein synthesis (30S ribosomal subunit)Gram + and Gram – and intracellular orgs.

Page 12: Antibacterial susceptibility testing

http://gsbs.utmb.edu/microbook/ch011.htm

Macrolides

Tetracycline

Page 13: Antibacterial susceptibility testing

Mechanisms of action

Oxazolidinones

LinezolidInhibit protein synthesis (50S ribosomal subunit)Gram + and Gram – including multi-resistant

Streptogramins

Quinupristin/dalfopristin (Synercid)Inhibit protein sythesis (50S ribosomal subunit)Primarily Gram + organisms

Page 14: Antibacterial susceptibility testing

Linezolid

http://www.kcom.edu/faculty/chamberlain/Website/Lects/Metabo.htm

Streptogramins

Page 15: Antibacterial susceptibility testing

Mechanisms of action

Trimethoprim

Sulfonamides

Usually combined (Trimeth/sulfa)Inhibit different parts of folic acid pathway

affects DNA synthesisGram + and many Gram –

Page 16: Antibacterial susceptibility testing

http://gsbs.utmb.edu/microbook/ch011.htm

Page 17: Antibacterial susceptibility testing

Mechanisms of resistance

Biologic

- physiologic changes resulting in a decreasein susceptibility

Clinical

- physiologic changes have progressed to a pointwhere drug is no longer clinically useful

Page 18: Antibacterial susceptibility testing

Mechanisms of resistance

Environmentally-mediated

Physical or chemical characteristics that alter theagent or the organism’s physiologic response tothe drug

pHanaerobiasiscationsmetabolites

Page 19: Antibacterial susceptibility testing

Mechanisms of resistance

Microorganism-mediated

Intrinsic predictable

Gram neg vs. vancomycin (uptake)

Klebsiella vs. ampicillin (AmpC)

Aerobes vs. metronidazole (anaerobic activation)

Page 20: Antibacterial susceptibility testing

Mechanisms of resistance

Microorganism-mediated

Acquired unpredictable- this is why we test- mutations, gene transfer, or combination

Page 21: Antibacterial susceptibility testing

Mechanisms of resistance

These factors are taken into account to attemptto standardize in vitro testing methods.

In vitro methods are not designed to recreatein vivo physiology.

In vivo physiology affects clinical response suchthat in vitro testing cannot be used to predictclinical outcome.

Page 22: Antibacterial susceptibility testing

Mechanisms of resistance

Common pathways

1. Enzymatic degradation or modification of agent

2. Decreased uptake or accumulation of agent

3. Altered target

4. Circumvention of consequences of agent

5. Uncoupling of agent-target interactions

6. Any combination of above

Page 23: Antibacterial susceptibility testing

Emergence of resistance

Mixing of bacterialgene pool

Selective pressure fromexcessive antimicrobial

use and abuse

Survival of the fittest

Page 24: Antibacterial susceptibility testing

Emergence of resistance

1. Emergence of new genes- MRSA, VRE, GISA

2. Spread of old genes to new hosts- Pen resistant GC , GRSA

3. Mutations of old genes resulting in more potent resistance- ESBLs

4. Emergence of intrinsically resistant opportunistic bacteria- Stenatrophomonas